This trial is testing whether nasal packing is necessary after surgery to remove pituitary tumors. The surgeon will randomly assign patients to either have nasal packing or not have packing, and then compare the outcomes between the two groups. The study will address whether it is feasible to enroll patients and get institutional approval for the trial.
- Pituitary Tumors
2 Primary · 4 Secondary · Reporting Duration: Through study completion, 1 year.
2 Treatment Groups
1 of 2
No Nasal Packing
1 of 2
60 Total Participants · 2 Treatment Groups
Primary Treatment: No nasal packing. · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has recruitment for this experiment been opened up?
"Affirmative. Clinicaltrials.gov attest that this medical experiment, which was first advertised on January 20th 2019, is currently recruiting patients. The study seeks 60 participants from a single medical centre." - Anonymous Online Contributor
What purpose does this clinical research endeavor to fulfill?
"This clinical trial is designed to quantify the incidence of sinonasal adverse events at Post Op Day 0, 1, 2, 3 and Post-Op weeks 2 and 4. Along with this primary outcome measure, Change in Analgesic and Antibiotic Usage (total dosage administered during study period), Cost Analysis (direct/indirect costs associated with hospitalization & medication) and Post operative Pain (measured via VAS from 0 - 10) will also be assessed as secondary objectives." - Anonymous Online Contributor
What is the sample size for this experiment?
"Affirmative. According to the clinicaltrials.gov webpage, this medical experiment is currently recruiting participants and was posted on January 20th 2019. The most recent update of the study occurred on April 19th 2022 with a goal of enrolling 60 patients at one site." - Anonymous Online Contributor